Aug. 1 at 4:40 AM
$BHVN Petition below is from the CEO of the National Ataxia Foundation urging the FDA to accelerate treatment options for SCA which currently has no approved therapies.
BIOHAVEN’s Troriluzole is the only treatment that has reached advanced clinical stages, has strong safety data, shows real-world evidence of benefit, and is supported by SCA medical experts!
Other investigational treatments are 5+ yrs away from possible FDA review.
https://www.change.org/p/urging-fda-to-consider-treatment-options-for-rare-diseases-with-unmet-needs-including-sca?source_location=psf_petitions
